dsRNA compositions and methods for treating HPV infection

Details for Australian Patent Application No. 2007230995 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Tan, Pamela; Benson, John; Fitzgerald, Kevin; Bramlage, Birgit; Vornlocher, Hans-Peter

Agent FB Rice

Pub. Number AU-B-2007230995

PCT Pub. Number WO2007/111998

Priority 60/785,837 24.03.06 US; 60/825,782 15.09.06 US

Filing date 23 March 2007

Wipo publication date 4 October 2007

Acceptance publication date 11 August 2011

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/111998 Priority application(s): WO2007/111998

18 February 2010 Assignment before Grant

  Novartis AG The application has been assigned to Alnylam Pharmaceuticals, Inc.

11 August 2011 Application Accepted

  Published as AU-B-2007230995

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007230997-Treatment of pain

2007230991-Compounds and methods for treatment of disorders associated with ER stress